GUARDION HEALTH (GHSI)
(Delayed Data from NSDQ)
$13.11 USD
+1.66 (14.50%)
Updated Aug 29, 2024 04:00 PM ET
After-Market: $12.60 -0.51 (-3.89%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMIncome Statements
Fiscal Year end for GUARDION HEALTH falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 12 | 11 | 7 | 2 | 1 |
Cost Of Goods | 7 | 7 | 4 | 2 | 0 |
Gross Profit | 5 | 5 | 3 | 0 | 1 |
Selling & Adminstrative & Depr. & Amort Expenses | 10 | 22 | 28 | 8 | 11 |
Income After Depreciation & Amortization | -4 | -17 | -25 | -9 | -10 |
Non-Operating Income | 4 | 3 | 0 | 0 | 0 |
Interest Expense | 0 | 0 | 0 | 0 | 0 |
Pretax Income | 0 | -15 | -25 | -9 | -11 |
Income Taxes | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 0 | -15 | -25 | -9 | -11 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | 0 | -15 | -25 | -9 | -11 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -4 | -6 | -12 | -8 | -8 |
Depreciation & Amortization (Cash Flow) | 0 | 11 | 13 | 0 | 2 |
Income After Depreciation & Amortization | -4 | -17 | -25 | -9 | -10 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 1.27 | 1.12 | 0.47 | 0.29 | NA |
Diluted EPS Before Non-Recurring Items | 0.12 | -5.17 | -22.00 | -30.00 | NA |
Diluted Net EPS (GAAP) | 0.12 | -14.15 | -52.00 | -30.00 | -89.98 |
Fiscal Year end for GUARDION HEALTH falls in the month of December .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | 0.07 | 3.00 | 2.94 | 3.34 | 2.79 |
Cost Of Goods | 0.04 | 1.82 | 1.59 | 1.88 | 1.54 |
Gross Profit | 0.04 | 1.18 | 1.35 | 1.46 | 1.25 |
SG&A, R&D, and Dept/Amort Expenses | 1.42 | 2.73 | 2.04 | 2.23 | 2.26 |
Income After SG&A, R&D, and Dept/Amort Expenses | -1.38 | -1.55 | -0.69 | -0.77 | -1.01 |
Non-Operating Income | -0.75 | -3.19 | 1.38 | 1.15 | -0.16 |
Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Pretax Income | -2.13 | -4.75 | 0.42 | 0.37 | -1.17 |
Income Taxes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | -2.13 | -4.75 | 0.42 | 0.37 | -1.17 |
Extras & Discontinued Operations | 12.46 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | 10.32 | -4.75 | 0.42 | 0.37 | -1.17 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | 1.30 | 1.28 | 1.29 | 1.27 | 1.27 |
Diluted EPS Before Non-Recurring Items | -1.64 | -3.71 | 0.33 | 0.29 | -0.93 |
Diluted Net EPS (GAAP) | 7.96 | -3.71 | 0.34 | 0.29 | -0.93 |